Johnson & Johnson (BCBA:JNJ)

Market Cap	471.18T
Revenue (ttm)	95.67T
Net Income (ttm)	23.36T
Shares Out	n/a
EPS (ttm)	9,622.91
PE Ratio	20.17
Forward PE	14.68
Dividend	226.09 (1.71%)
Ex-Dividend Date	May 27, 2025

Volume	7,131
Average Volume	10,836
Open	13,325
Previous Close	13,225
Day's Range	13,025 - 13,325
52-Week Range	10,425 - 14,775
Beta	0.41
RSI	66.16
Earnings Date	Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD